San Diego, April 19, 2019 – Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its sponsorship of Beyond Type 1’s “Beyond Type Run,” an official charity partner of the 2019 TCS New York City Marathon.
“It is inspiring to see how people with diabetes can thrive, especially when they have the best diabetes management technology,” says John Sheridan, President and CEO of Tandem Diabetes Care. “Tandem Diabetes Care is proud to sponsor Beyond Type Run, and wishes all the runners well as they train for an exciting race day.”
Beyond Type Run has sent a team of athletes all living with type 1 diabetes to participate in the TCS New York City Marathon since 2017. As part of its sponsorship, Tandem will offer t:slim X2™ insulin pumps with Basal-IQ® technology for up to 30 marathoners with type 1 diabetes for use while training and during the race which takes participants through the five boroughs of Manhattan.
"Beyond Type 1 is thrilled to field our third and largest Beyond Type Run team for the TCS New York City Marathon, and is incredibly grateful for the support of Tandem Diabetes Care,” says Thom Scher, CEO of Beyond Type 1. “Insulin pump technology, like that developed by Tandem, supports athletes living with type 1 diabetes with tools to help them train for the big race and live beyond their diagnosis.”
The marathon takes place on November 3, 2019.
Applications to join the Beyond Type Run team are now being accepted.
For more information visit: beyondtype1.org/2019-tcs-nyc-marathon
Tandem Diabetes Care periodically provides sponsorships and grants for educational and empowerment programing in the diabetes community. Grants are awarded to qualified non-profit organizations with the mission to empower people with diabetes, and to assist local initiatives, events, and programing that support Tandem’s mission, its employees, and corporate citizenship.
About Beyond Type 1
Beyond Type 1 (www.beyondtype1.org) is a nonprofit organization changing what it means to live with diabetes. Through platforms, programs, resources, and grants, Beyond Type 1 is uniting the global diabetes community and providing solutions to improve lives today. Founded in 2015 with a focus on education, advocacy and the path to a cure for Type 1 diabetes, Beyond Type 1 has grown to also include programs for those with Type 2 diabetes. A new model of philanthropy, Beyond Type 1 aims to change what it means to live with chronic illness.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™ Insulin Pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring. Tandem is based in San Diego, California.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslimX2 and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at www.linkedin.com/company/TandemDiabetes.
Tandem Diabetes Care is a trademark of Tandem Diabetes Care, Inc., registered in the U.S. and other countries. t:slim X2 is a trademark of Tandem Diabetes Care, Inc.
Tandem Diabetes Care Contact Information:
Media: Steve Sabicer, 714-907-6264, firstname.lastname@example.org
Investors: Susan Morrison, 858-366-6900 x7005, IR@tandemdiabetes.com